Honorhealth Research Institute

This early-stage trial is testing a new drug called tegavivint for people with advanced colorectal cancer that has spread. The main goals are to find a safe dose and see if the drug, given alone or with standard treatments, can help shrink tumors. The study is for adults whose ca…